↓ Skip to main content

Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol

Overview of attention for article published in Frontiers in immunology, September 2021
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol
Published in
Frontiers in immunology, September 2021
DOI 10.3389/fimmu.2021.753319
Pubmed ID
Authors

Roos S. G. Sablerolles, Abraham Goorhuis, Corine H. GeurtsvanKessel, Rory D. de Vries, Anke L. W. Huckriede, Marion P. G. Koopmans, Melvin Lafeber, Douwe F. Postma, Debbie van Baarle, Leo G. Visser, Virgil A. S. H. Dalm, Neeltje A. Kootstra, Wim J. R. Rietdijk, P. Hugo M. van der Kuy

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 19%
Researcher 5 14%
Student > Ph. D. Student 4 11%
Other 3 8%
Student > Master 1 3%
Other 1 3%
Unknown 15 42%
Readers by discipline Count As %
Medicine and Dentistry 9 25%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Nursing and Health Professions 2 6%
Engineering 2 6%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 4 11%
Unknown 16 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 September 2021.
All research outputs
#20,280,855
of 25,791,495 outputs
Outputs from Frontiers in immunology
#23,028
of 32,392 outputs
Outputs of similar age
#312,840
of 437,737 outputs
Outputs of similar age from Frontiers in immunology
#1,007
of 1,402 outputs
Altmetric has tracked 25,791,495 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 32,392 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,737 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,402 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.